| 臺大學術典藏 |
2021-06-04T08:33:28Z |
Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways
|
Chen P.-H.; Peng C.-Y.; Pai H.-C.; Teng C.-M.; Chen C.-C.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-02T05:44:02Z |
Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo
|
Liao C.-H.; Pan S.-L.; JIH-HWA GUH; Chang Y.-L.; Pai H.-C.; Lin C.-H.; Teng C.-M. |
| 臺大學術典藏 |
2021-06-02T05:44:01Z |
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9
|
Liu Y.-N.; Pan S.-L.; Peng C.-Y.; JIH-HWA GUH; Huang D.-M.; Chang Y.-L.; Lin C.-H.; Pai H.-C.; Kuo S.-C.; Lee F.-Y.; Teng C.-M. |
| 臺大學術典藏 |
2021-06-02T05:43:55Z |
Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells
|
Chen T.-H.; Pan S.-L.; JIH-HWA GUH; Chen C.-C.; Huang Y.-T.; Pai H.-C.; Teng C.-M. |
| 臺大學術典藏 |
2021-06-02T05:43:50Z |
The indazole derivative YD-3 specifically inhibits thrombin-induced angiogenesis in vitro and in vivo
|
Peng C.-Y.; Pan S.-L.; Pai H.-C.; Tsai A.-C.; JIH-HWA GUH; Chang Y.-L.; Kuo S.-C.; Lee F.-Y.; Teng C.-M. |
| 臺大學術典藏 |
2020-12-29T06:37:48Z |
A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study
|
SZU-MIN HSIEH; Chang M.; Hsu Y.-S.; Liu M.-C.; Pai H.-C.; Chen T.-J.; Wang N.-C.; Lee W.-S.; Hsu W.-T.; Pan S.-C. |
| 臺大學術典藏 |
2020-09-30T02:30:07Z |
A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study
|
Sung-Ching Pan;Hsu W.-T.;Lee W.-S.;Wang N.-C.;Chen T.-J.;Liu M.-C.;Pai H.-C.;Hsu Y.-S.;Chang M.;Hsieh S.-M.; SUNG-CHING PAN; Hsu W.-T.; Lee W.-S.; Wang N.-C.; Chen T.-J.; Liu M.-C.; Pai H.-C.; Hsu Y.-S.; Chang M.; Hsieh S.-M. |
| 國立成功大學 |
2020 |
Continuity of care and the quality of life among patients with type 2 diabetes mellitus: A cross-sectional study in taiwan
|
Hsieh, P.-L.;Yang, F.-C.;Hu, Y.-F.;Chiu, Y.-W.;Chao, S.-Y.;Pai, H.-C.;Chen, H.-M. |
| 臺大學術典藏 |
2019-05-24T10:02:00Z |
Evaluation for the distribution of fouling deposition on the microfiltration membrane using high frequency ultrasound
|
Pai H.-C.;Huang C.-C.;Wang S.-H.;Lin Y.-H.;Tung K.-L.; Lin Y.-H.; Wang S.-H.; Huang C.-C.; Pai H.-C.; Tung K.-L. |
| 臺大學術典藏 |
2018-09-10T05:47:51Z |
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9
|
Liu, Y.-N.;Pan, S.-L.;Peng, C.-Y.;Guh, J.-H.;Huang, D.-M.;Chang, Y.-L.;Lin, C.-H.;Pai, H.-C.;Kuo, S.-C.;Lee, F.-Y.;Teng, C.-M.; JIH-HWA GUH; CHE-MING TENG |
| 國立成功大學 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L |
| 國立臺灣大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L; 鄧哲明 |
| 大葉大學 |
2013-06 |
Electroacupuncture and rosiglitazone combined therapy as a means of treating insulin resistance and type 2 diabetes mellitus : A randomized controlled trial.
|
Lin, R. T.;Pai, H. C.;Lee, Y. C.;Tzeng, C. Y.;Chang, C. H.;Hung, P. H.;Chen, Y. I;Hsu, Tai-Hao;Tsai, C. C.;Lin, J. G;Chang, S. L. |
| 中國醫藥大學 |
2010-03 |
Antitumor Agents. 272. Structure-Activity Relationships and In Vivo Selective Anti-Breast Cancer Activity of Novel Neo-tanshinlactone Analogues.
|
(Dong, Y.); (Shi, Q.); (Pai, H.C.); 彭婕妤(Chieh-Yu Peng); (Pan, S.L.); (Teng, C.M.); (Nakagawa-Goto K,); (Eva Y.-H. P. Lee,#); 李國雄(Lee, K.H.)* |
| 臺大學術典藏 |
2010 |
The indazole derivative YD-3 specifically inhibits thrombin-induced angiogenesis in vitro and in vivo
|
Peng, C.-Y.;Pan, S.-L.;Pai, H.-C.;Tsai, A.-C.;Guh, J.-H.;Chang, Y.-L.;Kuo, S.-C.;Lee, F.-Y.;Teng, C.-M.; JIH-HWA GUH; CHE-MING TENG |
